Transcript analysis of clonal vs. bulk PICs. (A) qRT-PCR transcript analysis of PIC markers PW1, CD34, and Sca-1 in clonal PICs, compared to bulk PICs. (B) qRT-PCR transcript analysis of pluripotency markers Oct3/4, Sox2, and Nanog in clonal PICs compared to bulk PICs. Bars represent the mean transcript copy number normalised to GAPDH. Error bars represent the standard deviation of the mean; nâ=â3. (PDF 84 kb
Figure S1. Quality control of the dataset. Figure S2. Surface marker analysis and GO enrichment anal...
Table S1. Participantsâ Baseline Characteristics. Table S2. Primary and secondary antibodies used....
Figure S3. Quantitation of mitochondria in the cells in the progenitor state (Ctrl), in (BMP4, Rosi,...
Flow cytometry and transcript analysis of C9 sub-clones vs. C9 PICs. (A) qRT-PCR transcript analysis...
PW1/Sca-1 flow cytometric analysis of bulk, clonal, and sub-clonal PICs. (A) Bulk expression of PW1 ...
Phenotypic stability of C9 over 20 culture passages. Flow cytometric analysis at (A) P2 and (B) P20 ...
List of all antibodies used in immunohistochemistry and immunocytochemistry. (PDF 90 kb
Table S3. Mitochondria quantitation data used in support of Additional file 3: Figure S1 (sheet 1)...
Flow cytometric analysis of the pluripotent markers (TRA-1-60, SSEA4), hematopoietic markers (CD34, ...
Figure S1. Showing characterization of human iPSCs and differentiated cardiomyocytes. (A) qRT-PCR de...
Table S1. Illumina-based microarray data on expression levels of FABP4, UCP1, ADIPOQ, CITED1, LIPASI...
Figure S1. Phenotypic characterization of hCPCs. hCPCs were characterized using specific cell marker...
Additional file 3: Figure S3. Characterization of iPSC-derived NPCs from two other iPSC clonal lines...
Figure S6. BAT differentiation potential of clonal lines that were re-derived from candidate culture...
Figure S2. Additional data on flow cytometry. (A) Expression of CD44, CD73, and CD90 in induced plur...
Figure S1. Quality control of the dataset. Figure S2. Surface marker analysis and GO enrichment anal...
Table S1. Participantsâ Baseline Characteristics. Table S2. Primary and secondary antibodies used....
Figure S3. Quantitation of mitochondria in the cells in the progenitor state (Ctrl), in (BMP4, Rosi,...
Flow cytometry and transcript analysis of C9 sub-clones vs. C9 PICs. (A) qRT-PCR transcript analysis...
PW1/Sca-1 flow cytometric analysis of bulk, clonal, and sub-clonal PICs. (A) Bulk expression of PW1 ...
Phenotypic stability of C9 over 20 culture passages. Flow cytometric analysis at (A) P2 and (B) P20 ...
List of all antibodies used in immunohistochemistry and immunocytochemistry. (PDF 90 kb
Table S3. Mitochondria quantitation data used in support of Additional file 3: Figure S1 (sheet 1)...
Flow cytometric analysis of the pluripotent markers (TRA-1-60, SSEA4), hematopoietic markers (CD34, ...
Figure S1. Showing characterization of human iPSCs and differentiated cardiomyocytes. (A) qRT-PCR de...
Table S1. Illumina-based microarray data on expression levels of FABP4, UCP1, ADIPOQ, CITED1, LIPASI...
Figure S1. Phenotypic characterization of hCPCs. hCPCs were characterized using specific cell marker...
Additional file 3: Figure S3. Characterization of iPSC-derived NPCs from two other iPSC clonal lines...
Figure S6. BAT differentiation potential of clonal lines that were re-derived from candidate culture...
Figure S2. Additional data on flow cytometry. (A) Expression of CD44, CD73, and CD90 in induced plur...
Figure S1. Quality control of the dataset. Figure S2. Surface marker analysis and GO enrichment anal...
Table S1. Participantsâ Baseline Characteristics. Table S2. Primary and secondary antibodies used....
Figure S3. Quantitation of mitochondria in the cells in the progenitor state (Ctrl), in (BMP4, Rosi,...